Investment in life sciences – healthcare, biotech, medical equipment – remains the most popular direct investment option for family offices, with more than double the amount invested in fintech/finance, the next most popular choice, according to data from FamCap Analytics.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in